Garcia-Manero, G., Saini, L., Zeidan, A., Yacoub, A., Maness, L., Traer, E., Foran, J., Mohan, S., Lübbert, M., Lodewyck, T., Xicoy, B., Amin, H., Bachiashvili, K., Yimer, H., Zhu, N., Al-Ali, H. K., Lopez, P. F., Sanz, G., Santini, V., Berdeja, J., Priego, V., Odenike, O., Heyrman, B., Valcárcel, D., Wan, Y., Chan, W., Oganesian, A., Sano, Y., Keer, H., Griffiths, E. (2025). Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes. Blood. https://doi.org/10.1182/blood-2025-790